{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:18:15Z","timestamp":1788376695688,"version":"build-2803163510"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vitiligo is an acquired autoimmune disorder with a worldwide prevalence of 0.5\u20131%. It is characterized by depigmented macules caused by the absence of melanocytes in the epidermis.The aim of the treatment for vitiligo is disease stabilization and repigmentation. Hence, different scores have been developed to assess disease severity and repigmentation in order to infer the therapeutic efficacy of the chosen treatment. Vitiligo is associated with social stigma and has an immense effect on the patients\u2019 quality of life. Hence, scores have been developed to assess the impact of the disease. A comprehensive literature search was conducted using keywords such as \u201cvitiligo,\u201d \u201cscoring system,\u201d \u201cactivity,\u201d \u201cextent,\u201d \u201carea,\u201d \u201crepigmentation,\u201d \u201cquality of life,\u201d \u201cvitiligo disease burden,\u201d and \u201cimpact,\u201d individually or in combination. Databases searched included PubMed, Embase, the Cochrane Library, and ScienceDirect. Articles published up to May 2025 were considered for inclusion. These scores are essential for evaluating vitiligo in medical research and clinical practice. These are needed for assessment, treatment evaluation, and monitoring disease progression. This review article summarizes the scoring systems used in day-to-day practice and research trials. Eleven scores assess the extent of disease and\/or repigmentation, while nine monitor disease activity. Seven scores evaluate the impact on patients\u2019 or their families\u2019 quality of life. Additional research is needed to assess the validity, reliability, and responsiveness of each score.<\/jats:p>","DOI":"10.4103\/idoj.idoj_1220_25","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:03:59Z","timestamp":1787331839000},"page":"627-638","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Scoring Systems in Vitiligo\u2014A Narrative Review"],"prefix":"10.4103","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8695-0282","authenticated-orcid":false,"given":"Shivani","family":"Bansal","sequence":"first","affiliation":[{"name":"Department of Dermatology, All India Institute of Medical Sciences, Bathinda, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja A","family":"Mrig","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Atal Bihari Vajpayee Institute of Health Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himani","family":"Chawla","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ayushmann Skin Hospital, Hanumangarh, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Sushama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, All India Institute of Medical Sciences, Bathinda, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Karadia","sequence":"additional","affiliation":[{"name":"Department of Dermatology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"R1-20260902","doi-asserted-by":"crossref","first-page":"e70014","DOI":"10.1111\/pcmr.70014","article-title":"Quality analysis of measurement properties of patient-reported outcome measures for vitiligo and of the studies assessing them: Asystematic review","volume":"38","author":"Duponselle","year":"2025","journal-title":"Pigment Cell Melanoma Res"},{"key":"R2-20260902","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/jdv.19448","article-title":"Clinician-reported outcome measures for the assessment of vitiligo: A scoping review","volume":"37","author":"Van Geel","year":"2023","journal-title":"J EurAcad Dermatol Venereol"},{"key":"R3-20260902","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.3390\/jcm14082548","article-title":"A quality analysis of the measurement properties of the clinician-reported outcome measures for vitiligo and of the studies assessing them: A systematic review","volume":"14","author":"Duponselle","year":"2025","journal-title":"J Clin Med"},{"key":"R4-20260902","first-page":"e834","article-title":"Reliability of measurement instruments for vitiligo extent and their feasibility: A meta-analysis","volume":"39","author":"Speeckaert","year":"2025","journal-title":"J EurAcad Dermatol Venereol"},{"key":"R5-20260902","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archderm.140.6.677","article-title":"Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: The vitiligo area scoring index","volume":"140","author":"Hamzavi","year":"2004","journal-title":"Arch Dermatol"},{"key":"R6-20260902","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s13555-022-00752-8","article-title":"Meaningful changes in what matters to individuals with vitiligo: Content validity and meaningful change thresholds of the vitiligo area scoring index (VASI)","volume":"12","author":"Kitchen","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"R7-20260902","first-page":"750342","article-title":"Disease severity indexes and treatment evaluation criteria in vitiligo","author":"Kawakami","year":"2011","journal-title":"Dermatol Res Pract2011"},{"key":"R8-20260902","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1111\/jdv.13161","article-title":"The validity, reliability and acceptability of the SAVASI; anew self-assessment score in vitiligo","volume":"29","author":"Komen","year":"2015","journal-title":"J EurAcad Dermatol Venereol"},{"key":"R9-20260902","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaad.2021.06.880","article-title":"Development and validation of the fingertip unit for assessing facial vitiligo area scoring index","volume":"86","author":"Bae","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R10-20260902","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jdin.2023.06.008","article-title":"Reliability of the vitiligo area scoring index measurement tool for vitiligo","volume":"16","author":"Pourang","year":"2023","journal-title":"JAAD Int"},{"key":"R11-20260902","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamadermatol.2024.4534","article-title":"Psychometric properties and meaningful change thresholds of the vitiligo area scoring index","volume":"161","author":"Ezzedine","year":"2025","journal-title":"JAMA Dermatol"},{"key":"R12-20260902","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jid.2015.12.040","article-title":"Development and validation of the vitiligo extent score (VES): An international collaborative initiative","volume":"136","author":"Van Geel","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R13-20260902","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s00403-024-03778-4","article-title":"A scoping review of the extent of the clinical research on the vitiligo extent score","volume":"317","author":"Orozco-Jim\u00e9nez","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"R14-20260902","first-page":"949","article-title":"Reliability, validity and feasibility of the vitiligo extent score (VES) and self-assessment vitiligo extent score (SA-VES) among vitiligo patients: A cross-cultural validation","volume":"14","author":"Chaweekulrat","year":"2021","journal-title":"ClinCosmetInvestig Dermatol"},{"key":"R15-20260902","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1111\/jocd.13311","article-title":"Comparative analysis of the body surface area calculation method used in vitiligo extent score vs the hand unit method used in vitiligo area severity index","volume":"19","author":"Mogawer","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"R16-20260902","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/bjd.21246","article-title":"Assessment of vitiligo area scoring index (VASI), facial-VASI and vitiligo extent score using standardized photography of patients with vitiligo","volume":"187","author":"Merhi","year":"2022","journal-title":"Br J Dermatol"},{"key":"R17-20260902","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jaad.2020.10.061","article-title":"Assessing the minimal important change in the vitiligo extent score and the self-assessment vitiligo extent score","volume":"85","author":"Uitentuis","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R18-20260902","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jaad.2016.09.034","article-title":"Internationalvitiligo score working group. Development and validation of a patient-reported outcome measure in vitiligo: The self-assessment vitiligoextent score (SA-VES)","volume":"76","author":"Van Geel","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R19-20260902","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2017.12.070","article-title":"The vitiligo extent score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo","volume":"79","author":"Van Geel","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R20-20260902","doi-asserted-by":"crossref","first-page":"e2023186","DOI":"10.5826\/dpc.1303a186","article-title":"Comparative analysis of the most used versus the recently developed vitiligo activity and extent scores and their change with treatment","volume":"13","author":"Youssef","year":"2023","journal-title":"Dermatol Pract Concept"},{"key":"R21-20260902","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/pcmr.12730","article-title":"East AsiaVitiligo Association. Development and validation of the vitiligo extent score for a target area (VESTA) to assess the treatment response of a target lesion","volume":"32","author":"Bae","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"R22-20260902","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1111\/jocd.15116","article-title":"Efficacy and safety of combined fractional ablative CO2 laser and 5 fluorouracil in the treatment of acral vitiligo: An open, uncontrolled study","volume":"21","author":"Weshahy","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"R23-20260902","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/pcmr.12784","article-title":"Participants of the Rome international VGICC\/VIS workshop. Validation of a physician global assessment tool for vitiligo extent: Results of an international vitiligo expert meeting","volume":"32","author":"Van Geel","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"R24-20260902","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jdv.16562","article-title":"Validation of a patient global assessment for extent, severity and impact to define the severity strata for the self assessmentvitiligo extent score (SA-VES)","volume":"35","author":"Van Geel","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R25-20260902","first-page":"81","article-title":"Vitiligo extent tensityindex (VETI) score: A new definition, assessment and treatment evaluation criteria in vitiligo","volume":"4","author":"Feily","year":"2014","journal-title":"Dermatol Pract Concept"},{"key":"R26-20260902","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.abd.2023.03.007","article-title":"Clinical profile of vitiligo patients and relationship with immuno-inflammatory markers","volume":"99","author":"Mascarenhas","year":"2024","journal-title":"An Bras Dermatol"},{"key":"R27-20260902","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/bjd.12147","article-title":"Vitiligo Potential repigmentation index: A simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy","volume":"168","author":"Benzekri","year":"2013","journal-title":"Br J Dermatol"},{"key":"R28-20260902","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/bjd.21671","article-title":"Using the vitiligo noticeability scale in clinical trials: Construct validity, interpretability, reliability and acceptability","volume":"187","author":"Batchelor","year":"2022","journal-title":"Br J Dermatol"},{"key":"R29-20260902","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/diagnostics14050494","article-title":"Vitiligo treated with combined piperine-based topical treatment and narrowband ultraviolet B therapy: Follow-up with reflectance confocal microscopy","volume":"14","author":"Bertoli","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"R30-20260902","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archderm.135.4.407","article-title":"Association of the K\u00f6bner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris","volume":"135","author":"Njoo","year":"1999","journal-title":"Arch Dermatol"},{"key":"R31-20260902","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/bjd.18950","article-title":"Reliability and validity of the vitiligo signs of activity score (VSAS)","volume":"183","author":"Van Geel","year":"2020","journal-title":"Br J Dermatol"},{"key":"R32-20260902","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/jdv.18134","article-title":"Assessing the dynamic changes in vitiligo: Reliability and validity of the vitiligo disease activity score (VDAS) and vitiligo disease improvement score (VDIS)","volume":"36","author":"Van Geel","year":"2022","journal-title":"J EurAcad Dermatol Venereol"},{"key":"R33-20260902","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1159\/000511890","article-title":"Development and validation of a new scoring tool to evaluate the clinical evolution of adult patients with nonsegmental vitiligo","volume":"237","author":"Peralta-Pedrero","year":"2021","journal-title":"Dermatology"},{"key":"R34-20260902","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/pcmr.12065","article-title":"Development and validation of the K-VSCOR for scoring Koebner's phenomenon in vitiligo\/non-segmental vitiligo","volume":"26","author":"Diallo","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"R35-20260902","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/0378-6323.107637","article-title":"Vitiligo impact scale: An instrument to assess the psychosocial burden of vitiligo","volume":"79","author":"Krishna","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R36-20260902","first-page":"997","article-title":"The dermatology life quality index 1994-2007: A comprehensive review of validation data and clinical results","volume":"159","author":"Basra","year":"2008","journal-title":"Br J Dermatol"},{"key":"R37-20260902","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.det.2011.11.003","article-title":"The Skindex instruments to measure the effects of skin disease on quality of life","volume":"30","author":"Chren","year":"2012","journal-title":"Dermatol Clin"},{"key":"R38-20260902","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000348466","article-title":"Development of a quality of life scale for vitiligo","volume":"226","author":"\u015eenol","year":"2013","journal-title":"Dermatology"},{"key":"R39-20260902","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/bjd.13093","article-title":"Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument","volume":"171","author":"Gupta","year":"2014","journal-title":"Br J Dermatol"},{"key":"R40-20260902","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/bjd.17040","article-title":"What do vitiligo impact scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach","volume":"180","author":"Gupta","year":"2019","journal-title":"Br J Dermatol"},{"key":"R41-20260902","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2012.01.038","article-title":"Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL)","volume":"69","author":"Lilly","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R42-20260902","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12955-016-0490-y","article-title":"Quality of life in patients with vitiligo: A cross-sectional study based on vitiligo quality of life index (VitiQoL)","volume":"14","author":"Hedayat","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"R43-20260902","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/JID.2015.398","article-title":"The vitiligo impact patient scale (VIPS): Development and validation of a vitiligo burden assessment tool","volume":"136","author":"Salzes","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R44-20260902","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaad.2019.02.008","article-title":"Cross-cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs)","volume":"81","author":"Ezzedine","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R45-20260902","doi-asserted-by":"crossref","first-page":"32","DOI":"10.25259\/IJDVL_928_20","article-title":"Family vitiligo impact scale: A scale to measure the quality-of-life of family members of patients with vitiligo","volume":"88","author":"Agrawal","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R46-20260902","first-page":"3","article-title":"Validation of VitBOD, a simple burden of disease instrument for vitiligo","author":"Sheth","year":"2015","journal-title":"Med Res Arch"},{"key":"R47-20260902","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"VETF Members. The definition and assessment of vitiligo: A consensus report of the Vitiligo European Task Force","volume":"20","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"R48-20260902","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bjd.13432","article-title":"Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo","volume":"172","author":"Komen","year":"2015","journal-title":"Br J Dermatol"},{"key":"R49-20260902","first-page":"5170","article-title":"Implication of convolutional neural network in the classification of vitiligo","volume":"7","author":"Kantoria","year":"2020","journal-title":"Int Res J Eng Technol (IRJET)"},{"key":"R50-20260902","doi-asserted-by":"crossref","first-page":"754202","DOI":"10.3389\/fmed.2021.754202","article-title":"Design and assessment of convolutional neural network basedmethods for vitiligo diagnosis","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R51-20260902","doi-asserted-by":"crossref","first-page":"590","DOI":"10.21037\/atm-22-1738","article-title":"A deep learning-based hybrid artificial intelligence model for the detection and severity assessment of vitiligo lesions","volume":"10","author":"Guo","year":"2022","journal-title":"Ann Transl Med"},{"key":"R52-20260902","first-page":"1024","article-title":"Deep learning based model for detection of vitiligo skin disease using pretrained inception V3","volume":"8","author":"Sharma","year":"2023","journal-title":"Int J Math EngManag Sci"},{"key":"R53-20260902","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1038\/s41598-024-59436-2","article-title":"Optimizing vitiligo diagnosis with resNet and swin transformer deep learning models: A study on performance and interpretability","volume":"14","author":"Zhong","year":"2024","journal-title":"Sci Rep"},{"key":"R54-20260902","first-page":"10981","article-title":"Vitiligo detection using machine learning","volume":"30","author":"Dixit","year":"2024","journal-title":"EducAdm Theory Pract"},{"key":"R55-20260902","first-page":"3277546","article-title":"Detection of vitiligo through machine learning and computer-aided techniques: A systematic review","author":"Tanvir","year":"2024","journal-title":"Biomed Res Int 2024"},{"key":"R56-20260902","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4103\/0378-6323.79699","article-title":"A measurement of the stigma among vitiligo and psoriasis patients in India","volume":"77","author":"Pichaimuthu","year":"2011","journal-title":"Indian J Dermatol VenereolLeprol"},{"key":"R57-20260902","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/bjd\/ljae020","article-title":"Stigma in vitiligo: Associated factors and severity strata of the Patient Unique Stigmatization Holistic tool in Dermatology (PUSH-D) score","volume":"190","author":"Fakih","year":"2024","journal-title":"Br J Dermatol"},{"key":"R58-20260902","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s44155-025-00204-6","article-title":"Stigma and vitiligo: The experience of stigma and quality of life in patients with vitiligo","volume":"5","author":"Massoodi","year":"2025","journal-title":"DiscovSoc Sci Health"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_1220_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:00:17Z","timestamp":1788375617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_1220_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_1220_25","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"2025-10-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}